Uptravi

Uptravi Indications/Uses

selexipag

Manufacturer:

Janssen-Cilag

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
UPTRAVI is indicated for the treatment of: idiopathic pulmonary arterial hypertension.
Heritable pulmonary arterial hypertension.
Pulmonary arterial hypertension associated with connective tissue disease.
Pulmonary arterial hypertension associated with congenital heart disease with repaired shunts.
Pulmonary arterial hypertension associated with drugs and toxins in patients with WHO functional class II, III or IV symptoms.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in